Frazier Life Sciences Acquisition Corp. II

EDGAR

Market value is not computed: no share count is recorded in its filings.

3 filing records in this dataset, filed from 2026-09-24 to 2026-10-22. Explore the available filing history and original sources.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-17.

Open-market purchases (code P)
1 transactions, 300,000 shares
Sum of shares × price per share: 3,000,000
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-10-15 Cha Albert P 300,000 10

5% holders (Schedule 13D and 13G)

  • Venrock Healthcare Capital Partners III, L.P. 9.0% SCHEDULE 13G 10/15/2026
  • VHCP Co-Investment Holdings III, LLC 9.0% SCHEDULE 13G 10/15/2026
  • Venrock Healthcare Capital Partners EG, L.P. 9.0% SCHEDULE 13G 10/15/2026

See all insider transactions

Registration statement

This company has filed to register securities with the SEC and has not yet filed an annual or quarterly report. Its financial statements are in the filing itself rather than structured data, so reported figures appear here once periodic reports are filed.

Offering terms · S-1 · 2026-09-24

Security
Class A ordinary shares, par value $0.0001 per share
Maximum offering price
USD 75,000,000
Registration fee
USD 10,357.5 · 0.0138%

The maximum offering price is the amount the registration fee is computed on, not what the company expects to raise. The offering size and price range are in the prospectus.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

3 filings · 0 latest values · 0 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0002153598, 2153598, FLSC, edgar:2153598

Also known as Frazier Life Sciences Acquisition Corp. II